Washington University School of Medicine received a $32 million National Institute on Aging grant to expand its longitudinal Alzheimer’s study through 2031. The project will evaluate real-world treatments and broaden community participation, aiming to increase the evidence base for how therapies perform outside controlled clinical settings. The funding underscores a continued shift toward pragmatic, community-inclusive Alzheimer’s research designs, with an emphasis on tracking outcomes over time as care practices evolve. The program’s duration is long enough to support multi-year follow-up on treatment patterns and disease trajectories.
Get the Daily Brief